Highly enantioselective rhodium‐catalyzed addition of arylboroxines to N‐unprotected ketimines is realized for the first time by employing chiral BIBOP‐type ligands with a Rh loading as low as 1 mol %. A range of c...
详细信息
Highly enantioselective rhodium‐catalyzed addition of arylboroxines to N‐unprotected ketimines is realized for the first time by employing chiral BIBOP‐type ligands with a Rh loading as low as 1 mol %. A range of chiral α‐trifluoromethyl‐α,α‐diaryl α‐tertiary amines or 3‐amino‐3‐aryloxindoles were formed with excellent ee values and yields by employing either WingPhos or PFBO‐BIBOP as the ligand. The method has enabled an efficient enantioselective synthesis of cipargamin.
A1 Predictive and prognostic biomarker panel for targeted application of radioembolisation improving individual outcomes in hepatocellular carcinoma Jella-Andrea Abraham, Olga Golubnitschaja A2 Integrated market acces...
A1 Predictive and prognostic biomarker panel for targeted application of radioembolisation improving individual outcomes in hepatocellular carcinoma Jella-Andrea Abraham, Olga Golubnitschaja A2 Integrated market access approach amplifying value of “Rx-CDx” Ildar Akhmetov A3 Disaster response: an opportunity to improve global healthcare Russell J. Andrews, Leonidas Quintana A4 USA PPPM: proscriptive, profligate, profiteering medicine-good for 1 % wealthy, not for 99 % unhealthy Russell J. Andrews A5 The role of IDO in a murine model of gingivitis: predictive and therapeutic potentials Babak Baban, Jun Yao Liu, Xu Qin, Tailing Wang, Mahmood S. Mozaffari A6 Specific diets for personalised treatment of diabetes type 2 Viktoriia V. Bati, Tamara V. Meleshko, Olga B. Levchuk, Nadiya V. Boyko A7 Towards personalized physiotherapeutic approach Joanna Bauer, Ewa Boerner, Halina Podbielska A8 Cells, animal, SHIME and in silico models for detection and verification of specific biomarkers of non-communicable chronic diseases Alojz Bomba, Viktor O. Petrov, Volodymyr G. Drobnych, Rostyslav V. Bubnov, Oksana M. Bykova, Nadiya V. Boyko A9 INTERACT-chronic care model: Self-treatment by patients with decision support e-Health solution Hans-Peter Brunner-La Rocca, Lutz Fleischhacker, Olga Golubnitschaja, Frank Heemskerk, Thomas Helms, Tiny Jaarsma, Judita Kinkorova, Jan Ramaekers, Peter Ruff, Ivana Schnur, Emilio Vanoli, Jose Verdu A10 PPPM in cardiovascular medicine in 2015 Hans-Peter Brunner-La Rocca A11 Magnetic resonance imaging of nanoparticles in mice, potential for theranostic and contrast media development – pilot results Rostyslav V. Bubnov, Sergiy A. Grabovetskyi, Olena M. Mykhalchenko, Natalia O. Tymoshok, Oleksandr B. Shcherbakov, Igor P. Semeniv, Mykola Y. Spivak A12 Ultrasound diagnosis for diabetic neuropathy - comparative study Rostyslav V. Bubnov, Tetyana V. Ostapenko A13 Ultrasound for stratification patients with diabetic foot ulcers for prevention and pers
作者:
BULL, DNDaniel N. Bull
Ph.D. is a consultant in fermentation technology and president of Satori Corporation P.O. Box 1730 Montclair N.J. 07042. (201) 783-9787.REFERENCES Graff G.M. Short H. and Keene J.1983. Gene-splicing methods move from lab to plant. Chem. Eng.90: 22-27.|ISI|Broda P.1979. p. 1-3. Plasmids. W. H. Freeman Oxford and San Francisco.Donoghue D.J. and Sharp P.A.1978. Construction of a hybrid bacteriophage-plasmid recombinant DNA vector. J. Bact.136: 1192-1196.|PubMed|ISI|ChemPort|Bok S.H. Hoppe D. Mueller D.C. and Lee S.E.1983. Improving the production of recombinant DNA proteins through fermentation development. Abstract from 186th ACS Natl. Mtg. Washington D.C. Sept. 1.Maniatis T. Fritsch E.F. and Sam-brook J.1982. p. 88. Molecular Cloning. Cold Spring Harbor Laboratory. Guidelines for research involving recombinant DNA molecules June 1983
Fed. Reg.48: 24556-24581. Modifications of physical containment recommendations for large-scale uses of organisms containing recombinant DNA molecules. 1983. Recomb. DNA Tech. Bull.6: 69-70.Bull D.N. Thoma R.W. and Stinnett T.E.1983. Bioreactors for submerged culture. In:Adv. in Biotechnological Proc. A. Mizrahi and A. L. van Wezel (eds.) 1: 1-30.Schmidli B.L. and Swartz R.W.1982. Design considerations for aseptic fermentation. Presentation at 184th ACS Natl. Mtg. Kanas City MO.Sittig W.1982. The present state of fermentation reactors. J. Chem. Tech. Biotechnol.32: 47-58.|ISI|Strek F.1963. Intl. Chem. Eng.3: 533.Uhl V.W. and Gray J.B.1996. Mixing Theory and Practice Vol. I. Academic Press New York.Peters M.S. and Timmerhaus K.D.1968. p. 542. Plant Design and Economics for Chemical Engineers. McGraw-Hill New York.Dickey D.S. and Hicks R.W. Fundamentals of agitation. Chem. Eng.83: 93-100.Oldshue J.Y.1983. Fluid mixing technology and practice. Chem. Eng.90: 82-108.Kipke K.D.1981. Heat transfer in aerated non-Newtonian fluids. Abstract from 2nd Eur. Cong. Biotech. Eastbourne UK April 5-10.Blakebrough N. McM
暂无评论